Company Filing History:
Years Active: 2004
Title: Lise Santoro: Innovator in Nucleic Acid Isolation
Introduction
Lise Santoro is a prominent inventor based in Sainte Foy les Lyons, France. She has made significant contributions to the field of nucleic acid isolation, showcasing her expertise and innovative spirit. With one patent to her name, she has developed a method that enhances the efficiency of nucleic acid extraction from various samples.
Latest Patents
Lise Santoro's patent focuses on a method for aqueous phase nucleic acid isolation from a sample. This method involves a series of steps, including nucleic acid adsorption on a particulate substrate. The process begins with the preparation of an adsorption reagent, which consists of a sol with an aqueous continuous phase and a dispersed particulate substrate phase. The functionalized particulate polymer used in this method is created through the polymerization of specific monomers and has a predetermined lower critical solubility temperature (LCST) of 25-45°C. The method includes several critical steps, such as contacting the sample with the adsorption reagent, selecting parameters for the reaction medium, separating the dispersed phase, and desorbing the nucleic acid.
Career Highlights
Lise Santoro is currently associated with bioMérieux, Inc., a company known for its innovative solutions in the field of diagnostics. Her work at bioMérieux has allowed her to apply her research in practical applications, contributing to advancements in medical and scientific fields.
Collaborations
Lise has collaborated with notable colleagues, including Philippe Cros and Abdelhamid Elaissari. These collaborations have further enriched her research and development efforts, leading to innovative solutions in nucleic acid isolation.
Conclusion
Lise Santoro's contributions to the field of nucleic acid isolation exemplify her innovative spirit and dedication to scientific advancement. Her patent reflects a significant step forward in the efficiency of nucleic acid extraction methods.